Annual Drug Patent Expirations for ARAZLO
Arazlo is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has nineteen patent family members in eighteen countries.
The generic ingredient in ARAZLO is tazarotene. One supplier is listed for this compound. Additional details are available on the tazarotene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
